The announcement of Aurinia Pharma exploring strategic alternatives to maximize shareholder value is a positive signal to investors. This indicates that the company is actively seeking ways to improve its financial performance, which could lead to increased profitability and a higher share price. Therefore, the short-term impact on the company's stock is likely to be positive.